Psyence Biomedical Ltd. - Ordinary Shares (PBM)

Loop Industries, Inc. (Nasdaq: LOOP) has launched Twist™, a branded, high-performance polyester resin made entirely from textile waste. Targeted at the fashion, sportswear, and home textile sectors, Twist™ delivers virgin-quality performance , full traceability, and up to 81% fewer CO₂ emissions than fossil-based alternatives.

Psyence Biomed (NASDAQ: PBM) has announced that its Chief of Global Impact, Mary-Elizabeth Gifford, was selected as a featured speaker at Psychedelic Science 2025 (“PS2025”) – the world’s largest international gathering focused on psychedelic research, biopharma, medicine, policy, and culture. Hosted by the Multidisciplinary Association for Psychedelic Studies (“MAPS”), the highly anticipated conference is taking place June 16-20, 2025, in Denver, Colorado. Psyence BioMed will present on business ethics in a panel session, “We are the Guardrails: Profit with Purpose.” In the role of Chief of Global Impact for Psyence Biomed, the first Nasdaq-listed biopharma with a focus on developing nature-derived (non-synthetic) psilocybin medicine for FDA approval, Gifford works in Washington, DC, to build bridges between research, regulation, and patient care.

New York, New York--(Newsfile Corp. - March 18, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence Biomed" or the "Company")...

Today's market update highlights exciting developments across key companies demonstrating innovation, growth potential, and strategic progress. From dividend shares and stock splits to groundbreaking medical advancements, these companies offer compelling opportunities for investors to watch.